Study details
Enrolling now
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Stanford University
NCT IDNCT06080074ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
50
Study length
about 2.5 years
Ages
0–16
Locations
5 sites in CA, NC, NY +2
What this study is about
This trial is testing a treatment called Cardiohelp, which is a type of ECMO (extracorporeal membrane oxygenation) device used to help children with severe heart failure. The goal is to see if this device is safe and effective for these young patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Cardiohelp device (VA-ECMO)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Injection / IVInjection / IV
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
bivalirudin, heparin
Drug routes
injection (Injection), injection
Endpoints
Secondary: Incidence of all serious adverse events
Body systems
Cardiology / Heart